Strategy for clinical evaluation and screening of sudden cardiac death relatives

Fundamental and Clinical Pharmacology

Volumn 24, Issue 5, 2010, Pages 619-635

  Ferrero Miliani, Laura ^a   Holst, Anders Gaarsdal ^b   Pehrson, Steen ^b   Morling, Niels ^a   Bundgaard, Henning ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

autopsy; family screening; genetics; inherited heart disease; molecular autopsy; sudden cardiac death

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; QUINIDINE;

ANAPHYLAXIS; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BLEEDING; BRUGADA SYNDROME; CARDIOLOGIST; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FABRY DISEASE; FAMILIAL AMYLOIDOSIS; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFORMATION PROCESSING; INTOXICATION; LONG QT SYNDROME; MORBIDITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SEIZURE; SEPTIC SHOCK; SHORT QT SYNDROME; SUDDEN DEATH;

ALGORITHMS; AUTOPSY; DEATH, SUDDEN, CARDIAC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEART DISEASES; HUMANS; MASS SCREENING;

EID: 77956989613     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00864.x     Document Type: Review

References (123)

1. Libby P., Robert B., Douglas M., Douglas Z. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th edn, Saunders, Philadelphia, 2007.
2. Morris V., Keelan T., Leen E. et al. Sudden cardiac death in the young: a 1-year post-mortem analysis in the Republic of Ireland. Ir. J. Med. Sci. (2009) 178 257 261.
3. Reddy P.R., Reinier K., Singh T. et al. Physical activity as a trigger of sudden cardiac arrest: the Oregon Sudden Unexpected Death Study. Int. J. Cardiol. (2009) 131 345 349.
4. Reinier K., Stecker E.C., Vickers C., Gunson K., Jui J., Chugh S.S. Incidence of sudden cardiac arrest is higher in areas of low socioeconomic status: a prospective two year study in a large United States community. Resuscitation (2006) 70 186 192.
5. Eijgelsheim M., Newton-Cheh C., Aarnoudse A.L. et al. Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study. Hum. Mol. Genet. (2009) 18 4213 4218.
6. Chugh S.S., Reinier K., Singh T. et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation (2009) 119 663 670.
7. Chugh S.S., Jui J., Gunson K. et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J. Am. Coll. Cardiol. (2004) 44 1268 1275.
8. Chugh S.S., Reinier K., Teodorescu C. et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. (2008) 51 213 228.
9. Papadakis M., Sharma S., Cox S., Sheppard M.N., Panoulas V.F., Behr E.R. The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales. Europace (2009) 11 1353 1358.
10. Wisten A., Forsberg H., Krantz P., Messner T. Sudden cardiac death in 15-35-year olds in Sweden during 1992-99. J. Intern. Med. (2002) 252 529 536.
11. Vaartjes I., Hendrix A., Hertogh E.M. et al. Sudden death in persons younger than 40 years of age: incidence and causes. Eur. J. Cardiovasc. Prev. Rehabil. (2009) 16 592 596.
12. Corrado D., Basso C., Pavei A., Michieli P., Schiavon M., Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA (2006) 296 1593 1601. (Pubitemid 44515020)
13. Puranik R., Chow C.K., Duflou J.A., Kilborn M.J., McGuire M.A. Sudden death in the young. Heart Rhythm (2005) 2 1277 1282.
14. Quigley F., Greene M., O'Connor D., Kelly F. A survey of the causes of sudden cardiac death in the under 35-year-age group. Ir. Med. J. (2005) 98 232 235.
15. Doolan A., Langlois N., Semsarian C. Causes of sudden cardiac death in young Australians. Med. J. Aust. (2004) 180 110 112.
16. Corrado D., Basso C., Rizzoli G., Schiavon M., Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J. Am. Coll. Cardiol. (2003) 42 1959 1963.
17. Behr E.R., Dalageorgou C., Christiansen M. et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur. Heart J. (2008) 29 1670 1680.
18. Tan H.L., Hofman N., van Langen I.M., van der Wal A.C., Wilde A.A. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation (2005) 112 207 213.
19. Behr E., Wood D., Wright M. et al. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet (2003) 362 1457 1459.
20. Tester D.J., Ackerman M.J. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J. Am. Coll. Cardiol. (2007) 49 240 246.
21. Chugh S.S., Senashova O., Watts A. et al. Postmortem molecular screening in unexplained sudden death. J. Am. Coll. Cardiol. (2004) 43 1625 1629.
22. Rodríguez-Calvo M.S., Brion M., Allegue C., Concheiro L., Carracedo A. Molecular genetics of sudden cardiac death. Forensic Sci. Int. (2008) 182 1 12.
23. Biros E., Karan M., Golledge J. Genetic variation and atherosclerosis. Curr. Genomics (2008) 9 29 42.
24. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). Online Mendelian Inheritance in Man, OMIM (TM) [Internet] [cited 2010 Jan 10] Available from: http://www.ncbi.nlm.nih.gov/omim/ .
25. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. J. Am. Coll. Cardiol. (2007) 50 2173 2195. (Pubitemid 350123680)
26. de la Grandmaison G.L. Is there progress in the autopsy diagnosis of sudden unexpected death in adults? Forensic Sci. Int. (2006) 156 138 144.
27. Basso C., Burke M., Fornes P. et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. (2008) 452 11 18.
28. Damani S.B., Topol E.J. Future use of genomics in coronary artery disease. J. Am. Coll. Cardiol. (2007) 50 1933 1940.
29. Jousilahti P., Puska P., Vartiainen E., Pekkanen J., Tuomilehto J. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J. Clin. Epidemiol. (1996) 49 497 503.
30. Graham I. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Atherosclerosis (2007) 194 1 45.
31. Fineschi V., Baroldi G., Silver M.D. Pathology of the Heart and Sudden Death in Forensic Medicine, 1st edn, CRC, Boca Raton, 2006.
32. Basso C., Calabrese F., Corrado D., Thiene G. Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc. Res. (2001) 50 290 300.
33. Maron B.J., McKenna W.J., Danielson G.K. et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll. Cardiol. (2003) 42 1687 1713.
34. Priori S. Task force on sudden cardiac death of the European Society of Cardiology. Eur. Heart J. (2001) 22 1374 1450.
35. Ostman-Smith I., Wettrell G., Keeton B. et al. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur. Heart J. (2008) 29 1160 1167.
36. Östman-Smith I., Wettrell G., Keeton B., Riesenfeld T., Holmgren D., Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol. Young (2005) 15 632 642.
37. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J. Am. Coll. Cardiol. (2006) 48 e247 e346.
38. Frank M.J., Stefadouros M.A., Watkins L.O., Prisant L.M., Abdulla A.M. Rhythm disturbances in hypertrophic cardiomyopathies: relationship to symptoms and the effect of 'complete' beta blockade. Eur. Heart J. (1983) 4 (Suppl F) 235 243.
39. Andersen P.S., Havndrup O., Hougs L. et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum. Mutat. (2009) 30 363 370.
40. Watkins H., McKenna W.J., Thierfelder L. et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. (1995) 332 1058 1065.
41. Hershberger R.E., Lindenfeld J., Mestroni L., Seidman C.E., Taylor M.R., Towbin J.A. Genetic Evaluation of Cardiomyopathy - A Heart Failure Society of America Practice Guideline. J. Card. Fail. (2009) 15 83 97.
42. Møller D.V., Andersen P.S., Hedley P. et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur. J. Hum. Genet. (2009) 17 1241 1249.
43. Burkett E.L., Hershberger R.E. Clinical and genetic issues in familial dilated cardiomyopathy. J. Am. Coll. Cardiol. (2005) 45 969 981.
44. Furlanello F., Bertoldi A., Dallago M. et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin. Electrophysiol. (1998) 21 331 335.
45. Corrado D., Basso C., Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc. Res. (2001) 50 399 408.
46. Robin N.H., Tabereaux P.B., Benza R., Korf B.R. Genetic testing in cardiovascular disease. J. Am. Coll. Cardiol. (2007) 50 727 737.
47. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur. Heart J. (2008) 29 270 276.
48. Pantazis A.A., Elliott P.M. Left ventricular noncompaction. Curr. Opin. Cardiol. (2009) 24 209 213.
49. Mogensen J., Arbustini E. Restrictive cardiomyopathy. Curr. Opin. Cardiol. (2009) 24 214 220.
50. Laney D., Fernhoff P. Diagnosis of Fabry Disease via Analysis of Family History. J. Genet. Couns. (2008) 17 79 83.
51. Roden D.M. Genetics of acquired long QT syndrome. J. Clin. Invest. (2005) 115 2025 2032.
52. Schwartz P.J., Stramba-Badiale M., Crotti L. et al. Prevalence of the congenital long-QT syndrome. Circulation (2009) 120 1761 1767.
53. Goldenberg I., Moss A.J. Long QT syndrome. J. Am. Coll. Cardiol. (2008) 51 2291 2300.
54. Chugh S. Sudden cardiac death with apparently normal heart: clinical implications of progress in pathophysiology. Card. Electrophysiol. Rev. (2001) 5 394 402.
55. Schwartz P.J., Priori S.G., Spazzolini C. et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 103 89 95.
56. Lunetta P., Levo A., Laitinen P., Fodstad H., Kontula K., Sajantila A. Molecular screening of selected long QT syndrome (LQTS) mutations in 165 consecutive bodies found in water. Int. J. Legal Med. (2003) 117 115 117.
57. Tester D.J., Kopplin L.J., Creighton W., Burke A.P., Ackerman M.J. Pathogenesis of unexplained drowning: new insights from a molecular autopsy. Mayo Clin. Proc. (2005) 80 596 600.
58. Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M., Ackerman M.J. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation (2004) 110 2119 2124.
59. Splawski I., Shen J., Timothy K.W. et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 102 1178 1185.
60. Hobbs J.B., Peterson D.R., Moss A.J. et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA (2006) 296 1249 1254.
61. Maron B.J., Thompson P.D., Puffer J.C. et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation (1996) 94 850 856.
62. Maron B.J., Zipes D.P. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities - general considerations. J. Am. Coll. Cardiol. (2005) 45 1318 1321.
63. Gussak I., Brugada P., Brugada J. et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 94 99 102.
64. Morita H., Wu J., Zipes D.P. The QT syndromes: long and short. Lancet (2008) 372 750 763.
65. Giustetto C., Di Monte F., Wolpert C. et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur. Heart J. (2006) 27 2440 2447.
66. Gaita F., Giustetto C., Bianchi F. et al. Short QT syndrome: a familial cause of sudden death. Circulation (2003) 108 965 970.
67. Triedman J.K. Brugada and short QT syndromes. Pacing Clin. Electrophysiol. (2009) 32 S58 S62.
68. Zareba W., Cygankiewicz I. Long QT syndrome and short QT syndrome. Prog. Cardiovasc. Dis. (2008) 51 264 278.
69. Antzelevitch C., Pollevick G.D., Cordeiro J.M. et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 115 442 449.
70. Hedley P.L., Jørgensen P., Schlamowitz S. et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum. Mutat. (2009) 30 1486 1511.
71. Patel U., Pavri B.B. Short QT syndrome. Cardiol. Rev. (2009) 17 300 303.
72. Schimpf R., Wolpert C., Bianchi F. et al. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J. Cardiovasc. Electrophysiol. (2003) 14 1273 1277.
73. Antzelevitch C., Brugada P., Borggrefe M. et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 111 659 670.
74. Fowler S.J., Priori S.G. Clinical spectrum of patients with a Brugada ECG. Curr. Opin. Cardiol. (2009) 24 74 81.
75. Benito B., Brugada R., Brugada J., Brugada P. Brugada syndrome. Prog. Cardiovasc. Dis. (2008) 51 1 22.
76. Hedley P.L., Jørgensen P., Schlamowitz S. et al. The genetic basis of Brugada syndrome: a mutation update. Hum. Mutat. (2009) 30 1256 1266.
77. Liu N., Ruan Y., Priori S.G. Catecholaminergic polymorphic ventricular tachycardia. Prog. Cardiovasc. Dis. (2008) 51 23 30.
78. Priori S.G., Napolitano C., Memmi M. et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation (2002) 106 69 74.
79. Hayashi M., Denjoy I., Extramiana F. et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation (2009) 119 2426 2434.
80. Fabre A., Sheppard M.N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart (2006) 92 316 320.
81. Cohle S.D., Sampson B.A. The negative autopsy: sudden cardiac death or other? Cardiovasc. Pathol. (2001) 10 219 222.
82. Carturan E., Tester D.J., Brost B.C., Basso C., Thiene G., Ackerman M.J. Postmortem genetic testing for conventional autopsy-negative sudden unexplained death. Am. J. Clin. Pathol. (2008) 129 391 397.
83. Wright C., Lee R.E.J. Investigating perinatal death: a review of the options when autopsy consent is refused. Arch. Dis. Child. Fetal Neonatal Ed. (2004) 89 F285 F288.
84. Weber M.A., Sebire N.J. Postmortem investigation of sudden unexpected death in infancy: current issues and autopsy protocol. Diagn. Histopathol. (2009) 15 510 523.
85. Elger B.S., Michaud K., Fellmann F., Mangin P. Sudden death: ethical and legal problems of post-mortem forensic genetic testing for hereditary cardiac diseases. Clin. Genet. [Internet] 2009 [cited 2010 Feb 1]) Available from: http://www.ncbi.nlm.nih.gov/pubmed/19863545.
86. Arvelige hjertesygdomme [Internet] (2006) Available from: http://cardio.synkron.com/graphics/toimport/cardio/user-graphics/Dokumenter/ rapporter-pdf/Arvelige-hjertesygd-rapport.pdf.
87. Kärkkäinen S., Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann. Med. (2007) 39 91 107.
88. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc. Res. (2008) 77 659 666.
89. Keren A., Syrris P., McKenna W.J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med. (2008) 5 158 168.
90. Mauban J.R.H., O'Donnell M., Warrier S., Manni S., Bond M. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (2009) 24 78 87.
91. Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J., Kass R.S. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc. Natl Acad. Sci. USA (2007) 104 20990 20995.
92. Hashemi S.M., Hund T.J., Mohler P.J. Cardiac ankyrins in health and disease. J. Mol. Cell. Cardiol. (2009) 47 203 209.
93. Modell S.M., Lehmann M.H. The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet. Med. (2006) 8 143 155.
94. Schimpf R., Borggrefe M., Wolpert C. Clinical and molecular genetics of the short QT syndrome. Curr. Opin. Cardiol. (2008) 23 192 198.
95. Balijepalli R.C., Kamp T.J. Caveolae, ion channels and cardiac arrhythmias. Prog. Biophys. Mol. Biol. (2008) 98 149 160.
96. Williams T.M., Lisanti M.P. The Caveolin genes: from cell biology to medicine. Ann. Med. (2004) 36 584 595.
97. Zwaag P.A.V.D., Jongbloed J.D., Berg M.P.V.D. et al. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum. Mutat. (2009) 30 1278 1283.
98. Awad M.M., Calkins H., Judge D.P. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. (2008) 5 258 267.
99. Zarate Y.A., Hopkin R.J. Fabry's disease. Lancet (2008) 372 1427 1435.
100. Yang Y., Li J., Lin X. et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J. Hum. Genet. (2009) 54 277 283.
101. Olson T.M., Alekseev A.E., Liu X.K. et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum. Mol. Genet. (2006) 15 2185 2191.
102. Tsai C., Lai L., Hwang J., Lin J., Chiang F. Molecular genetics of atrial fibrillation. J. Am. Coll. Cardiol. (2008) 52 241 250.
103. Ohno S., Toyoda F., Zankov D.P. et al. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum. Mutat. (2009) 30 557 563.
104. Schwartz P.J., Spazzolini C., Crotti L. et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation (2006) 113 783 790.
105. Peroz D., Rodriguez N., Choveau F., Baró I., Mérot J., Loussouarn G. Kv7.1 (KCNQ1) properties and channelopathies. J. Physiol. (Lond.) (2008) 586 1785 1789.
106. Maron B.J., Roberts W.C., Arad M. et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA (2009) 301 1253 1259.
107. Møller D.V., Pham T.T., Gustafsson F. et al. The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. (2009) 11 1031 1035.
108. Hougs L., Havndrup O., Bundgaard H. et al. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur. J. Hum. Genet. (2005) 13 161 165.
109. Walsh R., Rutland C., Thomas R., Loughna S. Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations. Cardiology (2009) 115 49 60.
110. Pfeufer A., Sanna S., Arking D.E. et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat. Genet. (2009) 41 407 414.
111. Newton-Cheh C., Eijgelsheim M., Rice K.M. et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat. Genet. (2009) 41 399 406.
112. Abraham R.L., Yang T., Blair M., Roden D.M., Darbar D. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J. Mol. Cell. Cardiol. (2010) 48 181 190.
113. Nolte I.M., Wallace C., Newhouse S.J. et al. Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS ONE (2009) 4 e6138.
114. Blayney L.M., Lai F.A. Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol. Ther. (2009) 123 151 177.
115. Watanabe H., Darbar D., Kaiser D.W. et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ. Arrhythm. Electrophysiol. (2009) 2 268 275.
116. Ruan Y., Liu N., Priori S.G. Sodium channel mutations and arrhythmias. Nat. Rev. Cardiol. (2009) 6 337 348.
117. Wu G., Ai T., Kim J.J. et al. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circ. Arrhythm. Electrophysiol. (2008) 1 193 201.
118. Merner N.D., Hodgkinson K.A., Haywood A.F. et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet. (2008) 82 809 821.
119. Watkins H., Ashrafian H., McKenna W.J. The genetics of hypertrophic cardiomyopathy: Teare redux. Heart (2008) 94 1264 1268.
120. Basso C., Corrado D., Marcus F.I., Nava A., Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 373 1289 1300.
121. Tester D.J., Will M.L., Haglund C.M., Ackerman M.J. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J. Am. Coll. Cardiol. (2006) 47 764 768.
122. Priori S.G., Napolitano C., Gasparini M. et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation (2002) 105 1342 1347. (Pubitemid 34260426)
123. Humphries S.E., Norbury G., Leigh S., Hadfield S.G., Nair D. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Curr. Opin. Lipidol. (2008) 19 362 368.